CORC

在结果中检索

CORC

浏览/检索结果: 共59条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy 期刊论文
FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 卷号: 9
作者:  Yuan, Meiqin;  Wang, Zeng;  Lv, Wangxia;  Pan, Hongming
收藏  |  浏览/下载：20/0  |  提交时间：2022/05/16
Pulmonary enteric adenocarcinoma 期刊论文
TRANSLATIONAL ONCOLOGY, 2021, 卷号: 14
作者:  Gong, Jiali;  Fan, Ying;  Lu, Hongyang
收藏  |  浏览/下载：54/0  |  提交时间：2021/11/01
Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study 期刊论文
BMC CANCER, 2019, 卷号: 19
作者:  Chang, Jinjia;  Lin, Guangyi;  Ye, Min;  Tong, Duo;  Zhao, Jing
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial 期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载：113/0  |  提交时间：2019/12/05
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase I 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 28
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载：43/0  |  提交时间：2020/01/03
Patients with RAS wild-type right-sided unresectable liver-confined mCRC also benefit from cetuximab plus chemotherapy in first-line treatment 期刊论文
AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 卷号: 8, 期号: 11
作者:  Wei, Ye;  Zheng, Peng;  Ren, Li;  Feng, Qingyang;  Zhu, Dexiang
收藏  |  浏览/下载：24/0  |  提交时间：2019/12/05
Additional Biomarkers beyond RAS That Impact the Efficacy of Cetuximab plus Chemotherapy in mCRC: A Retrospective Biomarker Analysis 期刊论文
JOURNAL OF ONCOLOGY, 2018
作者:  Zheng, Peng;  Liang, Chunmin;  Ren, Li;  Zhu, Dexiang;  Feng, Qingyang
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Quality-adjusted time without symptoms or toxicity (Q-TWiST) of patients with metastatic colorectal cancer (mCRC) treated with fruquintinib in a phase II clinical trial. 会议论文
作者:  Li, Jin;  Xu, Ruihua;  Bai, Yuxian;  Xu, Jianming;  Liu, Tianshu
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study 期刊论文
FUTURE ONCOLOGY, 2018, 卷号: 14, 期号: 20
作者:  Li, Jin;  Xu, Ruihua;  Qin, Shukui;  Liu, Tianshu;  Pan, Hongming
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study 期刊论文
FUTURE ONCOLOGY, 2018, 卷号: Vol.14 No.20, 页码: 2030-2043
作者:  Li, Jin;  Xu, Ruihua;  Qin, Shukui;  Liu, Tianshu;  Pan, Hongming
收藏  |  浏览/下载：4/0  |  提交时间：2019/02/25

©版权所有 ©2017 CSpace - Powered by CSpace